Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 27:10:e13775.
doi: 10.7717/peerj.13775. eCollection 2022.

Effects of bone morphogenetic protein 4 on TGF- β 1-induced cell proliferation, apoptosis, activation and differentiation in mouse lung fibroblasts via ERK/p38 MAPK signaling pathway

Affiliations

Effects of bone morphogenetic protein 4 on TGF- β 1-induced cell proliferation, apoptosis, activation and differentiation in mouse lung fibroblasts via ERK/p38 MAPK signaling pathway

Zhou Cai et al. PeerJ. .

Abstract

Fibroblasts, in particular myofibroblasts, are the critical effector cells in idiopathic pulmonary fibrosis (IPF), a deadly lung disease characterized by abnormal lung remodeling and the formation of "fibroblastic foci". Aberrant activation of TGF-β1 is frequently encountered and promotes fibroblast proliferation, activation, and differentiation in pulmonary fibrosis. Hence, the inhibition of TGF-β1-induced lung fibroblast activation holds promise as a therapeutic strategy for IPF. The present study aimed to investigate the potential effect and underlying mechanisms of bone morphogenetic protein 4 (BMP4) on TGF-β1-induced proliferation, apoptosis, activation and myofibroblast differentiation of adult lung fibroblasts. Here, we demonstrated that BMP4 expression was significantly decreased in TGF-β1-stimulated mouse primary lung fibroblasts (PLFs). BMP4 inhibited proliferation and apoptosis resistance of TGF-β1-stimulated mouse PLFs. BMP4 suppressed TGF-β1-induced fibroblast activation and differentiation in mouse PLFs. We also found that BMP4 inhibited TGF-β1-induced ERK and p38 MAPK phosphorylation. Our findings indicate that BMP4 exerts its anti-fibrotic effects by regulating fibroblast proliferation, apoptosis, activation and differentiation via the inhibition of the ERK/p38 MAPK signaling pathway, and thus has a potential for the treatment of pulmonary fibrosis.

Keywords: Activation; Apoptosis; BMP4; Fibroblasts; Pulmonary fibrosis; TGF-β1.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no competing interests.

Figures

Figure 1
Figure 1. BMP4 was decreased in TGF- β1-stimulated mouse primary lung fibroblasts (PLFs).
(A) qRT-PCR analysis of BMP4 mRNA levels in mouse PLFs stimulated with TGF- β1 (10 ng/ml) for 48 h. (B) Western blot analysis of BMP4 protein expression in mouse PLFs stimulated with TGF- β1 for 48 h. Data were expressed as mean ± SEM, **p < 0.01; ***p < 0.001.
Figure 2
Figure 2. BMP4 inhibited TGF- β1-induced proliferation of mouse PLFs.
(A–C) Western blot analysis of PCNA and Survivin in total cell lysates of PLFs from BMP4+/ + and BMP4+/− mice treated with TGF- β1 (10 ng/ml, 48 h). β-actin was used as a loading control. (D–E) Western blot analysis of PCNA and Survivin protein expressions in total cell lysates of WT PLFs treated with TGF- β1 (10 ng/ml, 48 h) and/or BMP4 (20 µM). β-actin was used as a loading control. Data were expressed as mean ± SEM, **p < 0.01; ****p < 0.0001.
Figure 3
Figure 3. BMP4 promoted cell apoptosis in TGF- β1-stimulated mouse PLFs.
(A) PLFs from BMP4+/ + and BMP4+/− mice were treated with TGF- β1 (10 ng/mL) for 48 h. The cells were double-stained with Annexin V-FITC and PI, and then the cellular apoptosis was determined by flow cytometry. (B) The ratio of apoptotic cells was statistically analyzed. (C) Western blot analysis of Bcl-2 in total cell lysates of PLFs from BMP4+/ + and BMP4+/− mice treated with TGF- β1 (10 ng/ml, 48 h). β-actin was used as a loading control. (D) Western blot analysis of Bcl-2 protein expression in total cell lysates of WT PLFs treated with TGF- β1 (10 ng/ml, 48 h) and/or BMP4 (20 µM). β-actin was used as a loading control. Data were expressed as mean ± SEM, *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 4
Figure 4. BMP4 suppressed TGF- β1-induced fibroblast activation and differentiation in mouse PLFs.
PLFs were incubated with TGF- β1 (10 ng/ml) in the absence or presence of BMP4 (20 µM) for 48 h. Western blot assay was used to detect FAP (A) and α-SMA (B) protein expression. β-actin was used as a loading control. Data were expressed as mean ± SEM, *p < 0.05; **p < 0.01; ***p < 0.001.
Figure 5
Figure 5. BMP4 downregulated TGF- β1-activated ERK/p38 MAPK signaling in PLFs.
(A) Western blot analysis of phosphorylated and total ERK or p38 in total cell lysates of PLFs from BMP4+/ + and BMP4+/− mice treated with TGF- β1 (10 ng/ml, 48 h). β-actin was used as a loading control. (B) Western blot analysis of phosphorylated and total expression of ERK or p38 in total cell lysates ofPLFs treated with TGF- β1 (10 ng/ml) and/or BMP4 (20 µM). β-actin was used as a loading control. Data were expressed as mean ± SEM, *p < 0.05; **p < 0.01; ***p < 0.001.

Similar articles

Cited by

References

    1. Acharya PS, Zukas A, Chandan V, Katzenstein AL, Pure E. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Human Pathology. 2006;37:352–360. doi: 10.1016/j.humpath.2005.11.020. - DOI - PubMed
    1. Bellusci S, Henderson R, Winnier G, Oikawa T, Hogan BL. Evidence from normal expression and targeted misexpression that bone morphogenetic protein (Bmp-4) plays a role in mouse embryonic lung morphogenesis. Development. 1996;122:1693–1702. doi: 10.1242/dev.122.6.1693. - DOI - PubMed
    1. Beyan H, Goodier MR, Nawroly NS, Hawa MI, Bustin SA, Ogunkolade WB, Londei M, Yousaf N, Leslie RD. Altered monocyte cyclooxygenase response to lipopolysaccharide in type 1 diabetes. Diabetes. 2006;55:3439–3445. doi: 10.2337/db06-0447. - DOI - PubMed
    1. Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. The American Journal of Physiology-Lung Cellular and Molecular Physiology. 2005;288:L1146–L1153. doi: 10.1152/ajplung.00383.2004. - DOI - PubMed
    1. Chen YL, Zhang X, Bai J, Gai L, Ye XL, Zhang L, Xu Q, Zhang YX, Xu L, Li HP, Ding X. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation. Cell Death & Disease. 2013;4:e665. doi: 10.1038/cddis.2013.154. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources